Biomarker-Driven NSCLC Care: The Precision Medicine Model for Today and the Future

Download All
Learn more about current biomarkers you can use to personalize care for your patients with NSCLC, with downloadable slides and an on-demand webcast from a live symposium, and a ClinicalThought commentary answering audience questions from the live event.
Todd M. Bauer, MD
Sandip P. Patel, MD
Joshua Sabari, MD

Downloadable Slidesets

Download these slides from a live webinar for the most recent data on the best methods for molecular testing in NSCLC.

Sandip P. Patel, MD Released: April 11, 2022

Download these slides from a live webinar for a review of recent data on treatment selection for patients with EGFR- or KRAS-positive NSCLC.

Joshua Sabari, MD Released: April 11, 2022

Download these slides from a live webinar for the most recent data on optimal treatment approaches for patients with NSCLC that are positive for less common driver mutations, including ALK, ROS, RET, NTRK, and MET.

Todd M. Bauer, MD Released: April 11, 2022

On-Demand Webcast

In this on-demand webcast from a recent AACR satellite symposium, expert faculty highlight the use of biomarkers to guide treatment choices in non-small-cell lung cancer, including new data, recent approvals, and treatment guidelines.

Todd M. Bauer, MD Sandip P. Patel, MD Joshua Sabari, MD Physicians: maximum of 1.75 AMA PRA Category 1 Credits Released: May 12, 2022 Expired: May 11, 2023

ClinicalThought

Three experts review current molecular testing in NSCLC and discuss how they apply biomarkers to guide care of patients with targeted agents in real-world clinical practice.

Todd M. Bauer, MD Sandip P. Patel, MD Joshua Sabari, MD Released: May 26, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Lilly
Novartis Pharmaceuticals Corporation
Turning Point Therapeutics, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings